Hypercapnia and acidosis after oxygen therapy in patients with acute exacerbations of chronic airways obstruction is well recognised, and an understanding of its pathogenesis is essential if successful strategies to limit the rise in arterial carbon dioxide tension (Paco2) are to be designed.
The acute rise in Paco2 during oxygen therapy was first ascribed to reduced hypoxic drive (due to the rise in Pao2), an acquired insensitivity to carbon dioxide, and consequent hypoventilation.' This led to the introduction by Campbell of controlled oxygen therapy to give hypoxic patients a small increase in arterial oxygen tension (Pao2), sufficient to increase significantly the arterial oxygen saturation (Sao2), but not to depress seriously the ventilatory drive.2 Other mechanisms for this oxygen induced hypercapnia were considered (table 1) but were originally thought to be playing only a minor part. Recently new experimental data3 in patients with acute respiratory failure have cast doubt on the classic explanation of hypoventilation. Instead, it was suggested that the rise in alveolar oxygen tension reduces the adaptatory pulmonary vasoconstriction that normally helps to maintain ventilation-perfusion (VA/() matching. Thus a deterioration in VA/( matching rather than hypoventilation became the favoured explanation for the hypercapnia. Interpretation of data in this field is extremely difficult and there are inadequate experimental data available to prove one or other of these hypotheses.
The purpose of this article is to discuss the possible mechanisms of carbon dioxide retention after oxygen therapy and to re-examine the relevent data, particularly those of Aubier et al. 3 The conclusions are at variance with those of some other authors-namely: (a) release of hypoxic vasoconstriction has a minimal effect; (b) the major factor causing extra carbon dioxide retention is decreased hypoxic drive due to the rise in Pao2, as originally proposed; (c) the Haldane effect plays a smaller part in the steady state increase in Paco2 than previously supposed. VT PaCO2 where PECO2 = mixed expired CO2 tension.
RESULTS
They found3 that, initially, overall ventilation fell by 18% but then rose to 93% of the control level during the 15th minute of oxygen administration. Although the 7% fall in ventilation at the 15th minute was 897 898 The lower the initial Pao2 (as in an exacerbation) then the greater will be the loss of hypoxic drive when the inspired oxygen concentration is increased. As already discussed, the increase in PaCo2 will depend on the fall 899 in alveolar ventilation and the initial Paco2 rather than the overall ventilation. If the breathing pattern is rapid and shallow (as in an exacerbation) then a small fall in VT represents a large fall in alveolar ventilation, and if the Paco2 is already raised then a given fall in VA will produce a larger absolute rise in Paco2 than if it had been initially lower ( figure) .
The degree to which this rise in Paco2 is limited by the stimulation of ventilation depends on carbon dioxide sensitivity in the brainstem, the initial Paco2, and the capacity of the respiratory muscles to respond to increased drive, versus the impairment of the mechanics of the respiratory system. Since the centres in the brainstem responsible for carbon dioxide drive probably respond to changes in hydrogen ion concentration [ On the basis of these considerations alone, without the need to invoke different [H +] sensitivities, patients with high breathing frequencies, low tidal volumes, low Pao2, and already high Paco2 (all features of an acute exacerbation of chronic airways obstruction) would be expected to have the biggest changes in Paco2 after any reduction in hypoxic drive from oxygeIn therapy. Two groups have found the rises in Paco2 after oxygen therapy in stable chronic obstructive lung disease to correlate well with the initial degree of hypoxia and hypercapnia.9 10 These considerations suggest that the data on hypercapnia after oxygen therapy derived from patients with stable chronic obstructive lung disease might be relevant to acute exacerbations since there is no reason to believe that the underlying mechanisms are any different. EFFECT Horsfield et al'6 found a 10% rise in Paco2 and an accompanying 8% fall in ventilation in 17 patients with chronic airways obstruction after 80% oxygen breathing. There was also pulmonary vasodilation (cardiac output unchanged) but this was presumably not specifically in low V/( areas since the efficiency of carbon dioxide excretion was not affected. Using a gamma camera and nitrogen-13, Eiser et al7 demonstrated a small but significant redistribution of blood flow in six of 16 patients with chronic airways obstruction given 30% oxygen. The effect of this on gas exchange, however, was calculated to be inadequate to produce a rise in Paco2. Using a similar technique but longer equilibration times, Guenard et a"18 found no redistribution of blood flow in 17 patients with chronic airways obstruction breathing 30% oxygen, but noted a tendency for the overall reduction in ventilation observed (9-4%, p < 0 05) to The carbon dioxide content curve for blood depends on the degree of oxygenation of haemoglobin. The more oxygenated the haemoglobin the less carbon dioxide can be carried at a given Pco2; this produces a parallel shift of the relationship between Pco2 and the carbon dioxide content of blood (that is, the slope is unchanged) over the normal range of Pco2 and above. Thus if a hypoxaemic patient is given oxygen, the rise in arterial and venous oxygen saturation will cause carbon dioxide to be evolved and the Pco2 will rise (for example, by 6 mm Hg (0 8 kPa) when Paco2 is 65 mm Hg (8-7 kPa)) and oxygen saturation will go from 70% to 100%.'3 Christiansen et al first described this effect24 and Lenfant' drew up a nomogram based on in vitro, closed system data,25 using only the change in saturation and the starting Paco2 to predict the rise in Paco2. It has been suggested that the Haldane effect, through this mechanism, accounts for a calculable increase in the steady state Paco2 that follows the administration of oxygen. Although the Haldane effect does increase the Paco2 by this mechanism, it does so only transiently. In a closed system the Pco2 will rise, because the evolved carbon dioxide cannot escape; in vivo the majority of the extra carbon dioxide is blown off via the lungs. This transient rise in carbon dioxide evolution, early on during oxygen therapy, will produce an initial instability of the Paco2.
The Haldane effect does, however, influence carbon dioxide excretion from a non-homogeneous lung over the longer term in a subtle but smaller way.26 In gas exchange units with low V/Q, increasing inspired oxygen concentration will lead to bigger changes in oxygen saturation in capillary blood than in high V/3 units, where the blood is already well saturated. Thus more carbon dioxide will be evolved into these low V/Q alveoli because of the larger Haldane effect. Since ventilation to these alveoli is not increased, capillary Pco2, and hence Paco2, must rise. This reduction in the matching of carbon dioxide evolution to alveolar ventilation, with a consequent wider spread of Pco2 levels in the lung, will increase the alveolar-arterial gradient and physiological deadspace for 
